We are on a mission to make genomics a routine part of patient care.
Our team is made up of product experts, genetic counselors, seasoned engineers and serial entrepreneurs in the genomics space, most recently building Clear Genetics — including the GIA chatbot that served millions of patients — which was acquired by Invitae in 2019.
Product & StrategyBacked By
Founder StoryI grew up seeing the power of genetics up close. My father is a pediatric medical geneticist, and my mother is an epidemiologist. Dinner conversations focused on patients and the care they needed. From an early age I listened to stories of families looking for answers. I saw how life-changing genetic information could be—not just for diagnosis, but for understanding, guidance, and hope. I also saw how deeply grateful people were when they finally had access to thoughtful counseling and care.
That stayed with me, and I began sharing these stories with anyone who would listen.
I grew up seeing the power of genetics up close. My father is a pediatric medical geneticist, and my mother is an epidemiologist. Dinner conversations focused on patients and the care they needed. From an early age I listened to stories of families looking for answers. I saw how life-changing genetic information could be—not just for diagnosis, but for understanding, guidance, and hope. I also saw how deeply grateful people were when they finally had access to thoughtful counseling and care.
That stayed with me, and I began sharing these stories with anyone who would listen.
As genetics advanced, the science kept moving faster. New tests became available. Discoveries accelerated. Therapies became more precise and more promising. But getting those advances to patients was still far too hard.
Over and over, I saw the same problem: life-changing genetic information existed, but it was not reaching people in routine care. Access depended on where you lived, who your provider was, how much time the clinic had, and whether the right systems were in place. Genetics was advancing quickly, but the infrastructure to deliver it at scale was not.
I became determined to help close that gap.
As genetics advanced, the science kept moving faster. New tests became available. Discoveries accelerated. Therapies became more precise and more promising. But getting those advances to patients was still far too hard.
Over and over, I saw the same problem: life-changing genetic information existed, but it was not reaching people in routine care. Access depended on where you lived, who your provider was, how much time the clinic had, and whether the right systems were in place. Genetics was advancing quickly, but the infrastructure to deliver it at scale was not.
I became determined to help close that gap.
For the last 20 years, I have focused on building software to make genetic services more accessible. I met my husband along this journey and we've built these companies together.
Our work has included platforms to support universal carrier screening, and later Clear Genetics and GIA—the Genetic Information Assistant—which helped expand access to genetic education and counseling and was ultimately acquired by Invitae.
Across each chapter, the mission has stayed the same: use technology to make genetics easier to deliver, easier to understand, and available to more people.
For the last 20 years, I have focused on building software to make genetic services more accessible. I met my husband along this journey and we've built these companies together.
Our work has included platforms to support universal carrier screening, and later Clear Genetics and GIA—the Genetic Information Assistant—which helped expand access to genetic education and counseling and was ultimately acquired by Invitae.
Across each chapter, the mission has stayed the same: use technology to make genetics easier to deliver, easier to understand, and available to more people.
Over the years, I have had the privilege of working with many incredible teammates. They stayed with me through multiple companies, which allows us to build together from a place of trust. We've worked with forward-thinking providers, health systems, and care teams. By combining forces, we learned the real barriers to bringing genetics to the point of care.
The challenge is not only scientific. It is operational. It is workflow. It is education. It is follow-up. It is making sure the right patient is identified, the right information is shared, the right test is ordered, and the right care happens after results come back.
These are solvable problems, but only if we build for the realities of clinical care.
Over the years, I have had the privilege of working with many incredible teammates. They stayed with me through multiple companies, which allows us to build together from a place of trust. We've worked with forward-thinking providers, health systems, and care teams. By combining forces, we learned the real barriers to bringing genetics to the point of care.
The challenge is not only scientific. It is operational. It is workflow. It is education. It is follow-up. It is making sure the right patient is identified, the right information is shared, the right test is ordered, and the right care happens after results come back.
These are solvable problems, but only if we build for the realities of clinical care.
We believe technology can help close the gap between breakthrough genetic diagnostics and therapies and the people who need them. We believe genetics should not be a specialty service that reaches only a few. It should be part of everyday care. It should be available to every patient who can benefit from it. Nest exists to help make that possible. We are building the infrastructure to bring genetics into real clinical workflows—so providers can deliver it more easily, and patients can access it more equitably.
We believe technology can help close the gap between breakthrough genetic diagnostics and therapies and the people who need them. We believe genetics should not be a specialty service that reaches only a few. It should be part of everyday care. It should be available to every patient who can benefit from it. Nest exists to help make that possible. We are building the infrastructure to bring genetics into real clinical workflows—so providers can deliver it more easily, and patients can access it more equitably.
Nest exists not just to build software, but to help make genetics a service that is truly available to everyone.
Because when genomic-informed care reaches people at the right time, in the right way, it can change lives. And that is the future we are building toward every day.
Backed by Y-Combinator and driven by clinical integrity, we build beautiful, user-centered, evidence-based products that integrate genomics into provider workflows. The result is a seamless approach to delivering precision medicine at scale, from intake to long-term management.
